Synthesis and biological evaluation of decavanadate Na4Co(H2O)6V10O28·18H2O

Biomedicine and Pharmacotherapy

Volumn 63, Issue 1, 2009, Pages 51-55

  Zhai, Fengying ^a   Wang, Xiaohong ^a   Li, Dongliu ^a   Zhang, He ^b   Li, Rui ^c   Song, Liansheng ^b  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b Cancer Research on Prevention and Treatment   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Antitumoral activity; Apoptosis; Decavanadate

Indexed keywords

ANTINEOPLASTIC AGENT; DECAVANADIC ACID; UNCLASSIFIED DRUG; VANADIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG SCREENING; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; VANADATES;

EID: 58049161550     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.01.006     Document Type: Article

References (24)

1. +] less-than-or-equal-to 10. Chem Scr 25 (1985) 309-317
2. Crans D.C., and Shin P.K. Characterization of vanadium(V) complexes in aqueous-solutions ethanolamine-derived and glycine-derived complexes. J Am Chem Soc 116 (1994) 1305-1315
3. Crans D.C., and Schelble S.M. Vanadate dimer and tetramer both inhibit glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides. Biochemistry 29 (1990) 6698-6706
4. Crans D.C., and Simone C.M. Nonreductive interaction of vanadate with an enzyme containing a thiol-group in the active-site-glycerol-3-phosphate dehydrogenase. Biochemistry 30 (1991) 6734-6741
5. Crans D.C., Sudhakar K., and Zamborelli T. Interaction of rabbit muscle aldolase at high ionic strengths with vanadate and other oxoanions. J Biochem 31 (1992) 6812-6821
6. Boyd D.W., Kustin K., and Niwa M. Do vanadate polyanions inhibit phosphotransferase enzymes?. Biochim Biophys Acta 827 (1985) 472-475
7. Demaster E.G., and Mitchell R.A. Comparison of arsenate and vanadate as inhibitors or uncouplers of mitochondrial and glycolytic energy metabolism. Biochemistry 12 (1973) 3616-3621
8. Soman G., Chang Y.C., and Graves D.J. Effect of oxyanions of the early transition metals on rabbit skeletal muscle phosphorylase. Biochemistry 22 (1983) 4994-5000
9. 2) coordination mode. J Inorg Biochem 85 (2001) 179-186
10. Watanabe H., Nakai M., Komazawa K., and Sakurai H. Synthesis, characterization, and biological activity of a new potent class of anti-HIV agents, the peroxoniobium-substituted heteropolytungstates. J Med Chem 37 (1994) 876-877
11. 2) coordination mode; in vitro and in vivo evaluations in rats. J Inorg Biochem 80 (2000) 99-105
12. - by ascorbic acid and glutathione: kinetic studies of pro-drugs for the enhancement of insulin action. Inorg Chem 41 (2002) 1357-1364
13. Baran E.J. Oxovanadium(IV) and oxovanadium(V) complexes relevant to biological systems. J Inorg Biochem 80 (2000) 1-10
14. Rehder D. The coordination chemistry of vanadium as related to its biological functions. Coord Chem Rev 182 (1999) 297-322
15. Shechter Y., Goldwaser I., Mironchik M., Fridkin M., and Gefel D. Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes. Coord Chem Rev 237 (2003) 3-11
16. Rehder D. Biological and medicinal aspects of vanadium. Inorg Chem Commun 6 (2003) 604-617
17. In: Orvig C., Thompson K.H., Battell M., McNeill J.H., Sigel H., and Sigel A. (Eds). Metal ions in biological systems vol. 31 (1995), Marcel Dekker, New York 575-594
18. Rehder D. The bioinorganic chemistry of vanadium. Angew Chem Int Ed Engl 30 (1991) 148-167
19. Djordjevic C., and Galen L.W. Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium. J Inorg Biochem 25 (1985) 51-55
20. Tiago T., Paulo M., Carlos G.M., and Manuel A. Binding modes of decavanadate to myosin and inhibition of the actomyosin ATPase activity. Biochim Biophys Acta 1774 (2007) 474-480
21. David C.W., Helen R.P., Penelope J.B., Clifton E.F.R., William R.W., and William A. Denny Bis-tropolonato derivatives of Cobalt(III) complexes of bidentate aliphatic nitrogen mustards as potential hypoxia-selective cytotoxins. J Inorg Biochem 68 (1997) 215-224
22. Ahn G.O., Botting K.J., Patterson A.V., Ware D.C., Tercel M., and Wilson W.R. Radiolytic and cellular reduction of a novel hypoxia-activated cobalt(III) prodrug of a chloromethylbenzindoline DNA minor groove alkylator. Biochem Pharmacol 71 (2006) 1683-1694
23. Liu J.T. Synthesis, character and biological activity studies of vanadium complex. Chang Chun, China (2003) 146-147 p. 184-6
24. Wang X.H., Liu J.F., and Pope M.T. New polyoxometalate/starch nanomaterial: synthesis, characterization and antitumoral activity. J Chem Soc Dalton Trans 5 (2003) 957-960